SASCM guideline for daptomycin use in South Africa – 2017 update
Daptomycin is currently registered for use in treatment of complicated skin and skin structure infections (cSSSI) and Staphylococcus aureus bacteraemia. The role of daptomycin in treatment of severe Gram-positive infections needs to be considered outside of these specific and rigid indications. Base...
Main Authors: | Warren Lowman, Jennifer Coetzee, Olga Perovic |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2017-07-01
|
Series: | Southern African Journal of Infectious Diseases |
Subjects: | |
Online Access: | https://sajid.co.za/index.php/sajid/article/view/58 |
Similar Items
-
Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS)
by: Silvia Corcione, et al.
Published: (2022-01-01) -
A critical view on the current use of daptomycin in Spain: The daptomise study
by: Carmen Guadalupe Rodríguez González, et al.
Published: (2023-07-01) -
Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review
by: Carolina Osorio, et al.
Published: (2021-03-01) -
The Resistance to Host Antimicrobial Peptides in Infections Caused by Daptomycin-Resistant <i>Staphylococcus aureus</i>
by: Md Saruar Bhuiyan, et al.
Published: (2021-01-01) -
Getting to the heart of the matter—are two agents really better than one for the treatment of staphylococcal infective endocarditis?
by: James Donnelly, et al.
Published: (2024-05-01)